This inventor holds 1 USPTO granted patent. Top assignee: Triton Biosciences Inc.. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: **The Innovations of John S Ralston in the Field of Biotechnology**
Introduction
John S Ralston, an inventor based in San Ramon, California, has made significant contributions to the field of biotechnology. With a focus on synthetic peptides, his work addresses critical health issues related to the Human T-Cell Lymphotropic Virus Type I (HTLV-I). Ralston's patent showcases innovative approaches to diagnostics, therapeutics, and vaccine development.
Latest Patents
Ralston holds a notable patent titled "Peptides representing epitopic sites for the major HTLV-I envelope." This invention discloses synthetic peptides and antibodies that are vital for recognizing specific epitopes acknowledged by the human monoclonal antibody 0.5 .alpha., known for its ability to neutralize HTLV-I. The patent emphasizes the potential applications of these peptides and antibodies, either individually or combined with others pertaining to predominant antibodies found in HTLV-I seropositive sera.
Career Highlights
John S Ralston is currently affiliated with Triton Biosciences Inc., where he engages in pioneering research and development efforts in biotechnology. His academic background and expertise have positioned him at the forefront of innovative solutions aimed at managing and combating viral infections.
Collaborations
Throughout his career, Ralston has collaborated with esteemed colleagues, including Robert W Akita and Dagne L Florine. Together, they have contributed to a rich body of research that advances understanding and treatment of complex health challenges.
Conclusion
John S Ralston's work exemplifies the vital role of inventors in creating solutions that address pressing health concerns. His patent on synthetic peptides for HTLV-I highlights the importance of innovation in biotechnology, showcasing how individual inventors can lead to significant advancements in medical science. As Ralston continues his work at Triton Biosciences Inc., the potential for further impactful inventions remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile